Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Athersys Inc (NASDAQ:ATHX)

1.23
Delayed Data
As of Feb 05
 -0.01 / -0.81%
Today’s Change
0.90
Today|||52-Week Range
3.43
+19.42%
Year-to-Date
No recent news for Athersys Inc.

Today’s Trading

Previous close1.24
Today’s open1.23
Day’s range1.20 - 1.26
Volume200,414
Average volume (3 months)388,359
Market cap$103.3M
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+41.51%
Earnings growth (this year)-17.24%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-33.43%
P/E ratioNM
Price/Sales76.46
Price/Book4.61

Competitors

 Today’s
change
Today’s
% change
VVUSVIVUS Inc+0.03+3.01%
ALIMAlimera Sciences Inc-0.17-7.17%
ARQLArQule Inc-0.05-2.96%
PVCTProvectus Biopharmac...+0.03+6.11%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateMarch 10, 2016
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$1.6M
Annual profit (last year)-$22.1M
Net profit margin-1,360.57%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Gil van Bokkelen
President, Chief Operating Officer &
Secretary
William B. J. Lehmann
Corporate headquarters
Cleveland, Ohio

Forecasts

Partner Offers